首页> 外国专利> ANTIBODIES THAT BIND TO CLEAVED FORM OF MUTANT CALRETICULIN, AND DIAGNOSTIC, PREVENTIVE, OR THERAPEUTIC AGENT FOR MYELOPROLIFERATIVE NEOPLASM

ANTIBODIES THAT BIND TO CLEAVED FORM OF MUTANT CALRETICULIN, AND DIAGNOSTIC, PREVENTIVE, OR THERAPEUTIC AGENT FOR MYELOPROLIFERATIVE NEOPLASM

机译:结合突变钙网蛋白裂解形式的抗体,以及骨髓增生性肿瘤的诊断、预防或治疗剂

摘要

A diagnostic, preventive, or therapeutic agent may be used for a myeloproliferative neoplasm. An antibody or a functional fragment thereof that binds to a cleaved mutant CALR protein, may include an antigen-recognition site in (a) a polypeptide chain having an amino acid sequence set forth in SEQ ID NO: 1 or (b) a polypeptide chain having an amino acid sequence having deletion, substitution, or addition of one to several amino acids in SEQ ID NO: 1; and a diagnostic, preventive, or therapeutic agent for a myeloproliferative neoplasm containing the antibody.
机译:诊断、预防或治疗药物可用于骨髓增生性肿瘤。与切割的突变型CALR蛋白结合的抗体或其功能片段可包括(a)具有SEQ ID NO:1中所述氨基酸序列的多肽链中的抗原识别位点,或(b)具有具有SEQ ID NO:1中所述氨基酸序列的氨基酸序列的多肽链中的抗原识别位点;以及含有该抗体的骨髓增生性肿瘤的诊断、预防或治疗剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号